Simon Collins

Simon reports on treatment news and HIV research. He edits HIV Treatment Bulletin (HTB) and the i-Base treatment guides and co-ordinates the i-Base treatment information services. He has been an advocate for over 20 years and cofounded i-Base with other colleagues in April 2000.

Responses to COVID-19: latest options for treatment

Art AIDS America: a selection

Open letter: on futility of proposed UK PrEP study

Two PrEP crowdfunders – UK help needed today…

A simple ask in 2016: the UN goal of universal HIV treatment

Legal threat causes NHS England to rethink PrEP access to prevent HIV

Activists convince Washington Post that Pfizer lowers prices: global action highlights fairer alternatives – this story has been removed!

Open mic talk: HIV, HCV, new drugs and treatment access

Why dolutegravir might get us closer to ending AIDS – next step, further research…

Impact of early ART on lung function: START substudy

Bite-size news from EACS 2015… remarkable results with dolutegravir monotherapy

Buying generic medication online in the the UK: PrEP and hepatitis C

Why the 5000% price hike for pyrimethamine in the US is relevant in the UK

Activists call for urgency of NHS access to PrEP

START study reports 18 months early: impact will change guidelines globally

Are patient information leaflets for research studies too difficult to read? (April 2015)

Methmephangee – ChemSex vs recreational drug use

NHS PrEP access: ACT-UP demo and community statements

PrEP talk from Glasgow online as a webcast

PrEP: a community perspective (November 2014)

Post navigation